Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
EGRX - Eagle Pharmaceuticals Inc - Stock Price Chart
TickerEGRX [NASD, RUT]
CompanyEagle Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap43.39MEPS (ttm)0.91
P/E3.67EPS this Y-
Forward P/E-EPS next Y-
PEG1.36EPS past 5Y-3.56%
P/S0.17EPS next 5Y2.70%
P/B0.17EPS Q/Q153.33%
Dividend-Sales Q/Q-12.80%
Insider Own12.02%Inst Own81.50%
Insider Trans0.00%Inst Trans-1.44%
Short Float9.96%EarningsNov 16/b
Analyst Recom3.00Target Price17.00
Avg Volume153.46K52W Range3.50 - 23.52
May-22-24 09:00AM Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq (GlobeNewswire) -12.81%
Apr-30-24 08:00AM Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annual Meeting (GlobeNewswire)
Apr-15-24 07:00AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida (GlobeNewswire) +13.29%
Apr-12-24 04:05PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K (GlobeNewswire)
Feb-05-24 09:55AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Feb-01-24 04:05PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-26-24 12:33PM EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline February 9, 2024 (GlobeNewswire)
Jan-24-24 09:45AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-18-24 06:50AM Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio (GlobeNewswire)
Jan-12-24 10:12AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 02 '23Sale13.8710,694148,326545,447Nov 03 04:39 PM
Tarriff ScottCEONov 01 '23Sale13.8210,925150,984556,141Nov 03 04:39 PM
Graves MichaelDirectorOct 27 '23Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03 '23Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02 '23Sale15.239,511144,853577,800Oct 04 05:07 PM
PAVS - Paranovus Entertainment Technology Ltd - Stock Price Chart
TickerPAVS [NASD]
CompanyParanovus Entertainment Technology Ltd
CountryChina
IndustryPackaged Foods
Market Cap7.41MEPS (ttm)-11.51
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.14EPS next 5Y-
P/B0.69EPS Q/Q-
Dividend-Sales Q/Q-88.12%
Insider Own21.98%Inst Own0.29%
Insider Trans0.00%Inst Trans-25.83%
Short Float0.00%Earnings-
Analyst Recom1.00Target Price60.00
Avg Volume56.37K52W Range0.72 - 4.84
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. It operates through the following segments: Healthcare products, Automobile, Online Store, and Internet Information and Advertising Service. The company was founded on February 9, 2018 and is headquartered in Nanping City, China.
AIRJ - Montana Technologies Corp. - Stock Price Chart
TickerAIRJ [NASD]
CompanyMontana Technologies Corp.
CountryUSA
IndustryBuilding Products & Equipment
Market Cap913.86MEPS (ttm)-0.28
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-864.09%
Dividend-Sales Q/Q-
Insider Own76.51%Inst Own1.28%
Insider Trans0.00%Inst Trans2.14%
Short Float1.02%Earnings-
Analyst Recom-Target Price-
Avg Volume55.10K52W Range8.40 - 49.11
Montana Technologies Corp. operates as a thermal energy and water harvesting technology company. It provides efficient and sustainable air conditioning and pure water from air through its transformational AirJoule technology. The company was founded on March 14, 2024 and is headquartered in Ronan, MT.
OZK - Bank OZK - Stock Price Chart
TickerOZK [NASD]
CompanyBank OZK
CountryUSA
IndustryBanks - Regional
Market Cap4.56BEPS (ttm)5.97
P/E6.63EPS this Y4.04%
Forward P/E6.28EPS next Y3.28%
PEG0.55EPS past 5Y12.64%
P/S1.87EPS next 5Y12.00%
P/B0.91EPS Q/Q6.59%
Dividend3.94%Sales Q/Q39.79%
Insider Own6.25%Inst Own88.87%
Insider Trans0.00%Inst Trans-2.68%
Short Float11.84%EarningsApr 17/a
Analyst Recom2.90Target Price49.10
Avg Volume1.11M52W Range34.24 - 52.36
May-29-24Downgrade Citigroup Buy → Sell $57 → $37
Bank OZK engages in the provision of community banking services. The firm offers deposit services such as checking, savings, money market, time deposit, and individual retirement accounts. It also provides loan services including types of real estate, consumer, commercial, industrial, and agricultural loans. The company was founded in 1903 and is headquartered in Little Rock, AR.
AAL - American Airlines Group Inc - Stock Price Chart
TickerAAL [NASD, S&P 500]
CompanyAmerican Airlines Group Inc
CountryUSA
IndustryAirlines
Market Cap7.62BEPS (ttm)0.60
P/E19.47EPS this Y-13.49%
Forward P/E3.84EPS next Y31.92%
PEG0.41EPS past 5Y-17.73%
P/S0.14EPS next 5Y47.95%
P/B-EPS Q/Q-3229.61%
Dividend-Sales Q/Q3.13%
Insider Own1.41%Inst Own58.86%
Insider Trans-0.08%Inst Trans1.45%
Short Float8.24%EarningsApr 25/b
Analyst Recom2.32Target Price16.85
Avg Volume32.21M52W Range10.86 - 19.08
May-29-24Downgrade Jefferies Buy → Hold $17 → $12
May-29-24Downgrade Seaport Research Partners Buy → Neutral
May-29-24Reiterated TD Cowen Buy $18 → $16
American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly-owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Department of Transportation Domestic, Department of Transportation Latin America, Department of Transportation Atlantic, and Department of Transportation Pacific. The company was founded on December 9, 2013 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raja VasuEVP Chief Commercial OfficerDec 14 '23Sale14.307,545107,894321,608Dec 14 04:09 PM
Raja VasuEVP Chief Commercial OfficerNov 21 '23Sale12.295,12162,937334,049Nov 21 05:32 PM
Raja VasuEVP Chief Commercial OfficerNov 20 '23Sale12.235,29864,795339,170Nov 20 04:20 PM
CATX - Perspective Therapeutics Inc - Stock Price Chart
TickerCATX [AMEX]
CompanyPerspective Therapeutics Inc
CountryUSA
IndustryMedical Devices
Market Cap910.09MEPS (ttm)-0.09
P/E-EPS this Y42.02%
Forward P/E-EPS next Y-9.90%
PEG-EPS past 5Y-7.69%
P/S102.95EPS next 5Y-
P/B3.45EPS Q/Q-7.83%
Dividend-Sales Q/Q-82.29%
Insider Own26.66%Inst Own34.07%
Insider Trans52.61%Inst Trans-1.05%
Short Float3.09%EarningsMay 15/b
Analyst Recom1.00Target Price2.22
Avg Volume5.70M52W Range0.20 - 1.90
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Austin Mark JohnVP Finance/Prin Fin&Acct OfficApr 23 '24Option Exercise0.3630,00010,80084,030Apr 24 04:35 PM
Lantheus Alpha Therapy, LLC10% OwnerMar 06 '24Buy0.9560,431,03957,409,487116,773,394Mar 08 11:24 AM
Williamson Robert F IIIDirectorJan 30 '24Buy0.71127,20690,710338,761Feb 01 04:53 PM
Williamson Robert F IIIDirectorJan 29 '24Buy0.6425,26616,170211,555Jan 30 04:57 PM
Williamson Robert F IIIDirectorJan 26 '24Buy0.56110,61362,304186,289Jan 30 04:57 PM
BSFC - Blue Star Foods Corp - Stock Price Chart
TickerBSFC [NASD]
CompanyBlue Star Foods Corp
CountryUSA
IndustryPackaged Foods
Market Cap2.28MEPS (ttm)-40.59
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.35EPS next 5Y-
P/B0.67EPS Q/Q96.42%
Dividend-Sales Q/Q19.06%
Insider Own20.98%Inst Own1.24%
Insider Trans30.00%Inst Trans-
Short Float0.65%EarningsMay 20/b
Analyst Recom1.00Target Price1000.00
Avg Volume343.99K52W Range2.05 - 110.00
Blue Star Foods Corp. is an international seafood company, which processes, imports, packages, and sells refrigerated seafood products. It offers pasteurized crab meat and other seafood products under the Blue Star, Pacifika, Oceanica, Crab and Go Premium Seafood, Lubkin, First Choice, Good Stuff, and Coastal Pride Fresh brands. The company was founded by John Keeler on May 15, 1995 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Herian NubarDirectorFeb 28 '24Buy0.1021,0002,113224,736Mar 14 03:52 PM
Herian NubarDirectorJan 16 '24Buy0.1420,0002,780203,736Mar 14 03:52 PM
Herian NubarDirectorJan 02 '24Buy0.155,000742183,736Mar 14 03:52 PM
BHVN - Biohaven Ltd - Stock Price Chart
TickerBHVN [NYSE, RUT]
CompanyBiohaven Ltd
CountryUSA
IndustryBiotechnology
Market Cap2.93BEPS (ttm)-6.84
P/E-EPS this Y-28.89%
Forward P/E-EPS next Y10.53%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B9.00EPS Q/Q-112.85%
Dividend-Sales Q/Q-
Insider Own13.66%Inst Own84.38%
Insider Trans3.64%Inst Trans334.24%
Short Float12.64%EarningsMay 09/a
Analyst Recom1.09Target Price58.44
Avg Volume1.54M52W Range15.56 - 62.21
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHILDS JOHN WDirectorMay 13 '24Buy35.1728,5001,002,4702,283,341May 14 07:30 AM
Bailey GregoryDirectorMay 13 '24Buy34.1915,000512,8771,615,071May 15 07:31 AM
Bailey GregoryDirectorApr 24 '24Buy39.1825,503999,1691,600,071Apr 25 07:32 AM
CHILDS JOHN WDirectorApr 22 '24Buy41.00195,1217,999,9614,096,512Apr 23 07:54 AM
Coric VladChief Executive OfficerApr 22 '24Buy41.00121,9514,999,9911,788,417Apr 23 07:54 AM
GENE - Genetic Technologies Ltd. ADR - Stock Price Chart
TickerGENE [NASD]
CompanyGenetic Technologies Ltd. ADR
CountryAustralia
IndustryDiagnostics & Research
Market Cap8.33MEPS (ttm)-28.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y13.28%
P/S1.48EPS next 5Y-
P/B2.21EPS Q/Q95.41%
Dividend-Sales Q/Q-7.17%
Insider Own-Inst Own1.49%
Insider Trans-Inst Trans-58.04%
Short Float-EarningsFeb 23/a
Analyst Recom1.00Target Price6.87
Avg Volume49.55K52W Range1.80 - 5.15
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through ,the EasyDNA, AffinityDNA, and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
TRSG - Tungray Technologies Inc - Stock Price Chart
TickerTRSG [NASD]
CompanyTungray Technologies Inc
CountrySingapore
IndustryMetal Fabrication
Market Cap61.10MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own85.32%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float1.14%Earnings-
Analyst Recom-Target Price-
Avg Volume448.31K52W Range4.22 - 11.78
Tungray Technologies, Inc. is a holding company, which engages in the provision of customized industrial manufacturing solutions to original equipment manufacturers in the semiconductors, printers, electronics, and home appliances sectors. The company was founded by Wanjun Yao on June 1, 2022 and is headquartered in Singapore.
123456781020